Price as of close on Nov 3, 2026 · Financials updated Oct 6, 2026
Basics
Sector
Healthcare
Industry
Medical Distribution
Country
United States
Market cap
58.6B USD
Enterprise value
63.1B USD
Full-time employees
58,788
Overall health
Drawback:higher risk than most peers: less short-term liquidity (current ratio 0.88 vs a peer median of 2.59)higher risk: less liquidity (current ratio 0.88 vs peers 2.59)
About average: growth and valuation
Ranks #576 of 1,157 healthcare companies (top 50%)
Negative shareholders' equity. Liabilities exceed assets on the balance sheet.
Cardinal Health's liabilities exceed its assets on the balance sheet. Large share buybacks can cause this in healthy companies, but so can accumulated losses; either way, debt-based ratios need care.
Profits growing faster than sales. Since FY Jun 2023: revenue +24%, operating profit +247%.
Since FY Jun 2023, Cardinal Health's revenue grew 24% while operating profit grew 247%: each extra dollar of sales is adding more profit.
Cash flow well above reported profit. Free cash flow is 2.6× reported profit.
Free cash flow is 2.6× reported profit. Large non-cash charges, such as depreciation, amortization or stock-based pay, reduce reported profit without using cash.
Since last quarter: No major changeValuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 59 → 58
Share price +2.6%-1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Shareholders' equity is negative, so debt/equity counts as among the highest in its peer group33% base weight · Z-score -9.77Sector median: 0.2215 · MAD: 0.2039
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Cardinal Health
Is Cardinal Health getting weaker?
Its latest SEC filing (Sep 21, 2026) showed no major changes. Its overall score is unchanged at 52/100 since Oct 28, 2026.
How is Cardinal Health valued vs its peers?
Priced about in line with its peers. Valuation scores 58/100 against 1,393 healthcare peers.Earnings yield 2.9% vs a peer median of 1.5% (stronger than 61% of peers).Earnings yield 2.9% vs peers 1.5% (stronger than 61% of peers).
Is Cardinal Health growing?
At about the same pace as its peers. Growth scores 56/100 against 1,393 healthcare peers.Revenue growth 14.2% vs a peer median of 6.1% (stronger than 70% of peers).Revenue growth 14.2% vs peers 6.1% (stronger than 70% of peers).
How profitable is Cardinal Health?
More profitable than most of its peers. Profitability scores 85/100 against 1,393 healthcare peers.Return on invested capital 180.0% vs a peer median of 4.7% (stronger than 95% of peers).Return on invested capital 180.0% vs peers 4.7% (stronger than 95% of peers).Operating margin 1.0% vs a peer median of 7.1% (weaker than 65% of peers).Operating margin 1.0% vs peers 7.1% (weaker than 65% of peers).
How risky is Cardinal Health?
Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings.Beta 0.50 vs a peer median of 0.63 (stronger than 61% of peers).Beta 0.50 vs peers 0.63 (stronger than 61% of peers).Current ratio 0.88× vs a peer median of 2.59× (weaker than 92% of peers).Current ratio 0.88× vs peers 2.59× (weaker than 92% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Sep 21, 2026 · compared with the quarter ended Dec 31, 2025
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
244.7B USD
254.2B USD
+3.9%
Net income (12 months)
1.7B USD
1.7B USD
+3.1%
Operating margin
1.0%
1.0%
−0.0 pts
Free cash flow (12 months)
5.5B USD
4.5B USD
−17.8%
Debt
9.0B USD
8.9B USD
−1.6%
Cash
2.8B USD
4.9B USD
+74.9%
Shares outstanding
235.3M
232.6M
−1.2%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Healthcare · 301 companies
Valuations in Healthcare are within their usual range since 2016.
52% of months since 2016 were valued lower than now.
19% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +8% and earnings +24% (medians): earnings grew faster than prices.
Median price-to-sales is +63% vs the whole market, against a usual +119%.
2016Shaded: most expensive fifth of its range2026
Shown for Healthcare: too few Medical Distribution companies have a long enough history of their own.
Earnings-based measures are left out for now because many companies in Healthcare are losing money.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY Jun 2022
FY Jun 2023
FY Jun 2024
FY Jun 2025
FY Jun 2026
Change
Gross margin
3.6%
3.4%
3.3%
3.7%
3.8%
▲ 0.2 pts
Operating margin
-0.3%
0.4%
0.5%
1.0%
1.0%
▲ 0.0 pts
Net margin
-0.5%
0.2%
0.4%
0.7%
0.7%
▼ 0.0 pts
Return on assets (ROA)
-2.1%
0.8%
1.9%
2.9%
3.0%
▲ 0.1 pts
Return on equity (ROE)
—
—
—
—
—
—
Free cash flow margin
1.5%
1.2%
1.4%
0.8%
1.8%
▲ 0.9 pts
Current ratio
1.08×
1.00×
0.98×
0.94×
0.88×
▼ 5.6%
Quick ratio
0.57×
0.52×
0.56×
0.50×
0.49×
▼ 2.7%
Debt to equity
—
—
—
—
—
—
Interest coverage
-4.13×
8.95×
24.37×
10.58×
7.51×
▼ 29%
CAH price history
Price history is added with the daily price update and will appear after the next one.